Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Given the Data of Hommers and Colleagues, Valproic Acid Is Not an Unequivocal Inducer of Clozapine Metabolism.

Foerster KI, Theile D.

J Clin Psychopharmacol. 2019 Jul/Aug;39(4):419-420. doi: 10.1097/JCP.0000000000001072. No abstract available.

PMID:
31188239
2.

Development and Implementation of a Cancer Quality Index in Queensland, Australia: A Tool for Monitoring Cancer Care.

Walpole ET, Theile DE, Philpot S, Youl PH; for Cancer Alliance Queensland.

J Oncol Pract. 2019 Jul;15(7):e636-e643. doi: 10.1200/JOP.18.00372. Epub 2019 May 31. Erratum in: J Oncol Pract. 2019 Aug;15(8):462.

PMID:
31150310
3.

Outcomes After Rectal Cancer Surgery: A Population-Based Study Using Quality Indicators.

Youl P, Philpot S, Theile DE; for Cancer Alliance Queensland.

J Healthc Qual. 2019 Nov/Dec;41(6):e90-e100. doi: 10.1097/JHQ.0000000000000200.

PMID:
31135608
4.

Outcomes following radical cystectomy: a population-based study from Queensland, Australia.

Coughlin GD, Youl PH, Philpot S, Wright MJ, Honore M, Theile DE; for Cancer Alliance Queensland.

ANZ J Surg. 2019 Jun;89(6):752-757. doi: 10.1111/ans.15259. Epub 2019 May 14.

PMID:
31087817
5.

Pharmacodynamic monitoring using biomarkers to individualize pharmacotherapy.

Theile D, Cho WC.

Biomark Med. 2019 Apr;13(5):393-408. doi: 10.2217/bmm-2018-0355. Epub 2019 Mar 29.

PMID:
30924677
6.

Outcomes following colorectal cancer surgery: Results from a population-based study in Queensland, Australia, using quality indicators.

Theile DE, Philpot S, Blake M, Harrington J, Youl PH.

J Eval Clin Pract. 2019 Oct;25(5):834-842. doi: 10.1111/jep.13087. Epub 2018 Dec 21.

PMID:
30575221
7.

Elucidating the beneficial effects of melphalan, adriamycin, and corticoids in combination with bortezomib against multiple myeloma in vitro.

Schäfer J, Burhenne J, Weiss J, Theile D.

Naunyn Schmiedebergs Arch Pharmacol. 2019 Apr;392(4):461-466. doi: 10.1007/s00210-018-01602-1. Epub 2018 Dec 15.

PMID:
30554340
8.

Bosentan enhances in vitro bortezomib's anti-proliferative potency against multiple myeloma by mechanisms going beyond endothelin receptor blockade.

Schäfer J, Weiss J, Theile D.

Br J Haematol. 2019 Mar;184(6):1052-1055. doi: 10.1111/bjh.15241. Epub 2018 Apr 20. No abstract available.

PMID:
29676451
9.

Methadone against cancer: Lost in translation.

Theile D, Mikus G.

Int J Cancer. 2018 Oct 15;143(8):1840-1848. doi: 10.1002/ijc.31356. Epub 2018 Mar 23. Review.

10.

The pregnane X receptor (PXR) and the nuclear receptor corepressor 2 (NCoR2) modulate cell growth in head and neck squamous cell carcinoma.

Rigalli JP, Reichel M, Reuter T, Tocchetti GN, Dyckhoff G, Herold-Mende C, Theile D, Weiss J.

PLoS One. 2018 Feb 22;13(2):e0193242. doi: 10.1371/journal.pone.0193242. eCollection 2018.

11.

Bortezomib, carfilzomib and ixazomib do not mediate relevant transporter-based drug-drug interactions.

Clemens J, Welti L, Schäfer J, Seckinger A, Burhenne J, Theile D, Weiss J.

Oncol Lett. 2017 Sep;14(3):3185-3192. doi: 10.3892/ol.2017.6560. Epub 2017 Jul 8.

12.

t-Darpp stimulates protein kinase A activity by forming a complex with its RI regulatory subunit.

Theile D, Geng S, Denny EC, Momand J, Kane SE.

Cell Signal. 2017 Dec;40:53-61. doi: 10.1016/j.cellsig.2017.08.012. Epub 2017 Sep 1.

13.

Impact of enzalutamide and its main metabolite N-desmethyl enzalutamide on pharmacokinetically important drug metabolizing enzymes and drug transporters.

Weiss J, Kocher J, Mueller C, Rosenzweig S, Theile D.

Biopharm Drug Dispos. 2017 Dec;38(9):517-525. doi: 10.1002/bdd.2103. Epub 2017 Oct 30.

PMID:
28865089
14.

Cellular effect and efficacy of carfilzomib depends on cellular net concentration gradient.

Schäfer J, Welti L, Seckinger A, Burhenne J, Theile D, Weiss J.

Cancer Chemother Pharmacol. 2017 Jul;80(1):71-79. doi: 10.1007/s00280-017-3335-4. Epub 2017 May 12.

PMID:
28500557
15.

Under-Reported Aspects of Platinum Drug Pharmacology.

Theile D.

Molecules. 2017 Feb 28;22(3). pii: E382. doi: 10.3390/molecules22030382. Review.

16.

Clementine juice has the potential for drug interactions - In vitro comparison with grapefruit and mandarin juice.

Theile D, Hohmann N, Kiemel D, Gattuso G, Barreca D, Mikus G, Haefeli WE, Schwenger V, Weiss J.

Eur J Pharm Sci. 2017 Jan 15;97:247-256. doi: 10.1016/j.ejps.2016.11.021. Epub 2016 Nov 24.

PMID:
27890698
17.

Re: Analysis of mortality in colorectal surgery in the Bi-National Colorectal Cancer Audit.

Theile DE, Philpot S.

ANZ J Surg. 2016 Nov;86(11):951. doi: 10.1111/ans.13716. No abstract available.

PMID:
27784143
18.

Differential effects of the enantiomers of tamsulosin and tolterodine on P-glycoprotein and cytochrome P450 3A4.

Doricakova A, Theile D, Weiss J, Vrzal R.

Naunyn Schmiedebergs Arch Pharmacol. 2017 Jan;390(1):49-59. doi: 10.1007/s00210-016-1304-9. Epub 2016 Sep 27.

PMID:
27678410
19.

Proteasome inhibition correlates with intracellular bortezomib concentrations but not with antiproliferative effects after bolus treatment in myeloma cell lines.

Dettmer S, Theile D, Schäfer J, Seckinger A, Burhenne J, Weiss J.

Naunyn Schmiedebergs Arch Pharmacol. 2016 Oct;389(10):1091-101. doi: 10.1007/s00210-016-1276-9. Epub 2016 Jul 15.

PMID:
27422413
20.

Bortezomib and ixazomib protect firefly luciferase from degradation and can flaw respective reporter gene assays.

Becker JP, Clemens JR, Theile D, Weiss J.

Anal Biochem. 2016 Sep 15;509:124-129. doi: 10.1016/j.ab.2016.06.015. Epub 2016 Jun 17.

PMID:
27325500
21.

The phytoestrogen genistein enhances multidrug resistance in breast cancer cell lines by translational regulation of ABC transporters.

Rigalli JP, Tocchetti GN, Arana MR, Villanueva SS, Catania VA, Theile D, Ruiz ML, Weiss J.

Cancer Lett. 2016 Jun 28;376(1):165-72. doi: 10.1016/j.canlet.2016.03.040. Epub 2016 Mar 24.

PMID:
27033456
22.

Structural and functional evaluation of interaction between mammalian ribosomal RNA with platinum-containing antineoplastic drugs.

Theile D, Kos M.

Toxicol Lett. 2016 Feb 3;242:47-52. doi: 10.1016/j.toxlet.2015.11.027. Epub 2015 Nov 30.

PMID:
26656794
23.

Obatoclax as a perpetrator in drug-drug interactions and its efficacy in multidrug resistance cell lines.

Theile D, Allendorf D, Köhler BC, Jassowicz A, Weiss J.

J Pharm Pharmacol. 2015 Nov;67(11):1575-84. doi: 10.1111/jphp.12455. Epub 2015 Aug 10.

PMID:
26255619
24.

Role of NR1I2 (pregnane X receptor) polymorphisms in head and neck squamous cell carcinoma.

Reuter T, Warta R, Theile D, Meid AD, Rigalli JP, Mogler C, Herpel E, Grabe N, Lahrmann B, Plinkert PK, Herold-Mende C, Dyckhoff G, Haefeli WE, Weiss J.

Naunyn Schmiedebergs Arch Pharmacol. 2015 Nov;388(11):1141-50. doi: 10.1007/s00210-015-1150-1. Epub 2015 Jul 4.

PMID:
26141049
25.

Soft tissue reconstruction after compound tibial fracture: 235 cases over 12 years.

Wagels M, Rowe D, Senewiratne S, Read T, Theile DR.

J Plast Reconstr Aesthet Surg. 2015 Sep;68(9):1276-85. doi: 10.1016/j.bjps.2015.05.017. Epub 2015 Jun 9.

PMID:
26095651
26.

Effects of adrenolytic mitotane on drug elimination pathways assessed in vitro.

Theile D, Haefeli WE, Weiss J.

Endocrine. 2015 Aug;49(3):842-53. doi: 10.1007/s12020-014-0517-2. Epub 2014 Dec 27.

PMID:
25542188
27.

Desmethyl bosentan displays a similar in vitro interaction profile as bosentan.

Weiss J, Baumann S, Theile D, Haefeli WE.

Pulm Pharmacol Ther. 2015 Feb;30:80-6. doi: 10.1016/j.pupt.2014.12.001. Epub 2014 Dec 19.

PMID:
25535031
28.

Interaction potential of the multitargeted receptor tyrosine kinase inhibitor dovitinib with drug transporters and drug metabolising enzymes assessed in vitro.

Weiss J, Theile D, Dvorak Z, Haefeli WE.

Pharmaceutics. 2014 Dec 16;6(4):632-50. doi: 10.3390/pharmaceutics6040632.

29.

Enabling the success of academic health science centres in Australia: where is the leadership?

Theile DE, Scott IA, Martin JH, Gavrilidis A.

Med J Aust. 2014 Dec 11;201(11):636-8. No abstract available.

PMID:
25495302
30.

Cellular uptake kinetics of bortezomib in relation to efficacy in myeloma cells and the influence of drug transporters.

Clemens J, Seckinger A, Hose D, Theile D, Longo M, Haefeli WE, Burhenne J, Weiss J.

Cancer Chemother Pharmacol. 2015 Feb;75(2):281-91. doi: 10.1007/s00280-014-2643-1. Epub 2014 Dec 5.

PMID:
25477008
31.

Fetal calf sera can distort cell-based luminescent proteasome assays through heat-resistant chymotrypsin-like activity.

Dettmer S, Theile D, Seckinger A, Burhenne J, Weiss J.

Anal Biochem. 2015 Feb 15;471:23-5. doi: 10.1016/j.ab.2014.10.019. Epub 2014 Nov 4.

PMID:
25447494
32.

Association of drug transporter expression with mortality and progression-free survival in stage IV head and neck squamous cell carcinoma.

Warta R, Theile D, Mogler C, Herpel E, Grabe N, Lahrmann B, Plinkert PK, Herold-Mende C, Weiss J, Dyckhoff G.

PLoS One. 2014 Oct 2;9(9):e108908. doi: 10.1371/journal.pone.0108908. eCollection 2014.

33.

Comment on "Sweat but no gain": inhibiting proliferation of multidrug resistant cancer cells with "ersatzdroges".

Theile D, Weiss J.

Int J Cancer. 2015 May 1;136(9):2241-2. doi: 10.1002/ijc.29246. Epub 2014 Oct 10. No abstract available.

34.

Deceptive argumentation against diagnostic microdosing of anticancer drugs.

Theile D, Mikus G.

Int J Cancer. 2014 Oct 1;135(7):1753-4. doi: 10.1002/ijc.28806. Epub 2014 Mar 4. No abstract available.

35.

What, if all alerts were specific - estimating the potential impact on drug interaction alert burden.

Seidling HM, Klein U, Schaier M, Czock D, Theile D, Pruszydlo MG, Kaltschmidt J, Mikus G, Haefeli WE.

Int J Med Inform. 2014 Apr;83(4):285-91. doi: 10.1016/j.ijmedinf.2013.12.006. Epub 2014 Jan 13.

PMID:
24484781
36.

Response to re: history of lower limb reconstruction after trauma.

Wagels M, Rowe D, Senewiratne S, Theile DR.

ANZ J Surg. 2014 Jan-Feb;84(1-2):99. doi: 10.1111/ans.12467. No abstract available.

PMID:
24450794
37.

Antiproliferative efficacies but minor drug transporter inducing effects of paclitaxel, cisplatin, or 5-fluorouracil in a murine xenograft model for head and neck squamous cell carcinoma.

Theile D, Gal Z, Warta R, Rigalli JP, Lahrmann B, Grabe N, Herold-Mende C, Dyckhoff G, Weiss J.

Cancer Biol Ther. 2014 Apr;15(4):436-42. doi: 10.4161/cbt.27632. Epub 2014 Jan 21.

38.

Cisplatin, oxaliplatin, and carboplatin unequally inhibit in vitro mRNA translation.

Becker JP, Weiss J, Theile D.

Toxicol Lett. 2014 Feb 10;225(1):43-7. doi: 10.1016/j.toxlet.2013.11.015. Epub 2013 Nov 23.

PMID:
24275384
39.

In-vitro evaluation of chronic alcohol effects on expression of drug-metabolizing and drug-transporting proteins.

Theile D, Schmidt TT, Haefeli WE, Weiss J.

J Pharm Pharmacol. 2013 Oct;65(10):1518-25. doi: 10.1111/jphp.12124. Epub 2013 Jul 30.

PMID:
24028619
40.

The use of frozen section in the excision of cutaneous malignancy: a Queensland experience.

Castley AJ, Theile DR, Lambie D.

Ann Plast Surg. 2013 Oct;71(4):386-9. doi: 10.1097/SAP.0b013e31824f21f5.

PMID:
24025654
41.

Watch out for reporter gene assays with Renilla luciferase and paclitaxel.

Theile D, Spalwisz A, Weiss J.

Anal Biochem. 2013 Jun 15;437(2):109-10. doi: 10.1016/j.ab.2013.02.026. Epub 2013 Mar 7.

PMID:
23499973
42.

Minor role of pregnane-x-receptor for acquired multidrug resistance in head and neck squamous cell carcinoma in vitro.

Rigalli JP, Reuter T, Herold-Mende C, Dyckhoff G, Haefeli WE, Weiss J, Theile D.

Cancer Chemother Pharmacol. 2013 May;71(5):1335-43. doi: 10.1007/s00280-013-2133-x. Epub 2013 Mar 12.

PMID:
23479137
43.

Liposomal sphingomyelin influences the cellular lipid profile of human lymphoblastic leukemia cells without effect on P-glycoprotein activity.

Zembruski NC, Nguyen CD, Theile D, Ali RM, Herzog M, Hofhaus G, Heintz U, Burhenne J, Haefeli WE, Weiss J.

Mol Pharm. 2013 Mar 4;10(3):1020-34. doi: 10.1021/mp300485j. Epub 2013 Feb 19.

PMID:
23379426
44.

Interaction profile of macitentan, a new non-selective endothelin-1 receptor antagonist, in vitro.

Weiss J, Theile D, Rüppell MA, Speck T, Spalwisz A, Haefeli WE.

Eur J Pharmacol. 2013 Feb 15;701(1-3):168-75. doi: 10.1016/j.ejphar.2013.01.010. Epub 2013 Jan 23.

PMID:
23353592
45.

Regulation of biotransformation systems and ABC transporters by benznidazole in HepG2 cells: involvement of pregnane X-receptor.

Rigalli JP, Perdomo VG, Luquita MG, Villanueva SS, Arias A, Theile D, Weiss J, Mottino AD, Ruiz ML, Catania VA.

PLoS Negl Trop Dis. 2012;6(12):e1951. doi: 10.1371/journal.pntd.0001951. Epub 2012 Dec 13.

46.

Influence of sildenafil and tadalafil on the enzyme- and transporter-inducing effects of bosentan and ambrisentan in LS180 cells.

Weiss J, Theile D, Spalwisz A, Burhenne J, Riedel KD, Haefeli WE.

Biochem Pharmacol. 2013 Jan 15;85(2):265-73. doi: 10.1016/j.bcp.2012.11.020. Epub 2012 Dec 5.

PMID:
23219525
47.

Jejunal free flap reconstruction of the pharyngolaryngectomy defect: 368 consecutive cases.

Perez-Smith D, Wagels M, Theile DR.

J Plast Reconstr Aesthet Surg. 2013 Jan;66(1):9-15. doi: 10.1016/j.bjps.2012.08.033. Epub 2012 Sep 18.

PMID:
22995669
48.

History of lower limb reconstruction after trauma.

Wagels M, Rowe D, Senewiratne S, Theile DR.

ANZ J Surg. 2013 May;83(5):348-53. doi: 10.1111/j.1445-2197.2012.06271.x. Epub 2012 Sep 19.

PMID:
22989362
49.

Association of liver stiffness with hepatic expression of pharmacokinetically important genes in alcoholic liver disease.

Theile D, Haefeli WE, Seitz HK, Millonig G, Weiss J, Mueller S.

Alcohol Clin Exp Res. 2013 Jan;37 Suppl 1:E17-22. doi: 10.1111/j.1530-0277.2012.01901.x. Epub 2012 Jul 24.

PMID:
22827451
50.

Rifampicin alters the expression of reference genes used to normalize real-time quantitative RT-PCR data.

Weiss J, Theile D, Haefeli WE.

Naunyn Schmiedebergs Arch Pharmacol. 2012 Oct;385(10):1025-34. doi: 10.1007/s00210-012-0782-7. Epub 2012 Jul 24.

PMID:
22825545

Supplemental Content

Loading ...
Support Center